Pfizer Inc., et al v. Teva Pharmaceuticals USA, Inc.

  1. October 18, 2011

    Pfizer Wins Attys' Fees From Teva In Viagra Patent Row

    A Virginia federal judge on Monday granted Pfizer Inc. nearly $380,000 in attorneys' fees from Teva Pharmaceuticals USA Inc., ruling that the generics manufacturer pursued baseless inequitable conduct claims in a Viagra patent dispute.

  2. September 20, 2011

    How They Won It: Kaye Scholer Saves Pfizer's Viagra Patent

    To sell a federal judge on the ingenuity of using an angina drug to treat erectile dysfunction, Kaye Scholer LLP attorneys put Viagra's inventors on the stand to defeat Teva Pharmaceuticals USA Inc.'s patent challenge — something of a leap of faith, as anyone who's slogged through an incomprehensible freshman biology lecture knows.

  3. August 15, 2011

    Pfizer's Viagra Patent Survives Teva Challenge

    A Virginia federal judge on Friday rejected Teva Pharmaceuticals USA Inc.'s bid to sell a generic version of Viagra, ruling that a Pfizer Inc. patent for the blockbuster drug remains valid and enforceable.

  4. July 06, 2011

    Teva Asks Trial Judge To Dismiss Pfizer Viagra Suit

    As a bench trial in Virginia stretched into its eleventh day Wednesday, Teva Pharmaceuticals USA Inc. asked a federal judge to dismiss Pfizer Inc.'s infringement suit over a copycat version of blockbuster erectile dysfunction drug Viagra for lack of standing.

  5. March 31, 2010

    Pfizer Not Excited About Teva's Generic Viagra

    Pfizer Inc. has shot off a patent infringement suit against generic-drug maker Teva Pharmaceuticals USA Inc., seeking to stop the sale of a copycat version of blockbuster erectile dysfunction drug Viagra.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!